$PACS

Blue Orca and Iceberg Research published reports on EquipmentShare.com (EQPT) and Deep Fission (FISN), alleging financial and operational issues. EquipmentShare disputes the claims. Viceroy and Scorpion Capital raised concerns about Blue Moon Metals (BMM) and Twist Bioscience (TWST). Several companies, including Corcept Therapeutics (CORT), Nutanix (NTNX), and Zscaler (ZS), reported executive departures. Michael Burry warned of $3 trillion in AI-related commitments across major tech firms.

PACS Group Inc (NYSE:PACS) shares rose 2% in after-hours trading on Monday after appointing Patrick J. Murphy as Chief Legal Officer. Murphy, with extensive legal experience, succeeds John Mitchell, who retired but will consult during the transition. The company's CEO highlighted Murphy's relevant background for guiding PACS's growth.

PACS Group, Inc. (PACS) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 PACS Group Announces Chief Legal Officer Transition John Mitchell retires and continues in consultant role; Patrick J. Murphy appointed Chief Legal Officer effective September 21, 2026 Salt Lake City, Utah, September 21, 2026 — PACS Group, Inc. (“PACS” or the “Compan

Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $43.13 ($43.08–$43.62, $1.73M total) across 2 trades on 2026-09-16 under a Rule 10b5-1 trading plan.

Hancock Mark sold 300,000 shares of PACS Group, Inc. (PACS) at an average of $43.48 ($42.09–$44.91, $13.04M total) across 5 trades over 2026-09-14 to 2026-09-15 under a Rule 10b5-1 trading plan.

Murray Jason Hulse (Co-Founder, CEO & Chairman) sold 19,617 shares of PACS Group, Inc. (PACS) at an average of $45.19 ($45.03–$45.23, $0.89M total) across 3 trades over 2026-09-10 to 2026-09-14 under a Rule 10b5-1 trading plan.

Murray Jason Hulse (Co-Founder, CEO & Chairman) sold 51,887 shares of PACS Group, Inc. (PACS) at an average of $43.12 ($42.68–$43.59, $2.24M total) across 5 trades over 2026-09-04 to 2026-09-09 under a Rule 10b5-1 trading plan.

Murray Jason Hulse (Co-Founder, CEO & Chairman) sold 68,113 shares of PACS Group, Inc. (PACS) at an average of $42.63 ($42.35–$43.36, $2.90M total) across 6 trades over 2026-09-01 to 2026-09-03 under a Rule 10b5-1 trading plan.

PACS stock rose 3.3% premarket after announcing two growth initiatives: acquiring 32 Florida nursing facilities and closing 11 more from the Eduro Healthcare deal, expanding its network to 355 buildings. The company's stock has recovered from a 52-week low of $7.50, now trading at $43.52. PACS's low leverage and favorable Medicare reimbursements support its growth strategy.

PACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.